A. Schömig

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Albert Schömig, Albert W. Schömig, A. Schömig, A Schömig, Albert Schömig
Publication record
776 papers · 48,250 citations · H-index 111

PAPERS

Machine Learning Identifies New Predictors on Restenosis Risk after Coronary Artery Stenting in 10,004 Patients with Surveillance Angiography
20239 citationsauthor #10
Ten‐Year Clinical Outcomes of Biodegradable Versus Durable Polymer New‐Generation Drug‐Eluting Stent in Patients With Coronary Artery Disease With and Without Diabetes Mellitus
20216 citationsauthor #22
[Risk assessment].
20200 citationsauthor #3
Doesreducing capacitance havepotential for further miniaturisation ofimplantable defibrillators
20170 citationsauthor #4
COATINGS WITH BODEGRADABLE ELASTOMER AND RELEASABLE TAXANE AGENT
20170 citationsauthor #9
Acute Coronary Syndromes ender and Myocardial Salvage After eperfusion Treatment in Acute Myocardial Infarction
20160 citationsauthor #11
irolimus and Paclitaxel n Polymer-Based Drug-Eluting Stents imilar But Different
20160 citationsauthor #2
Long-term outcome after coronary stenting Adnan Kastrati , Donald Hall and Albert Schömig
20160 citationsauthor #3
uantitative Measurement of Infarct Size y Contrast-Enhanced Magnetic Resonance maging Early After Acute Myocardial Infarction omparison With Single-Photon mission Tomography Using Tc 99 m-Sestamibi
20160 citationsauthor #6
Stenting for Small Coronary Vessels : A
20160 citationsauthor #3
ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting.
2015409 citationsauthor #33
Acute and Midterm Outcome After MitraClip Therapy in Patients With Severe Mitral Regurgitation and Left Ventricular Dysfunction.
201525 citationsauthor #7
Evaluation ofa NewTreadmill Exercise Protocol
20150 citationsauthor #4
Dangerous liaison: successful percutaneous edge-to-edge mitral valve repair in patients with end-stage systolic heart failure can cause left ventricular thrombus formation.
201421 citationsauthor #8
Prognostic value of late gadolinium enhancement in cardiovascular magnetic resonance imaging after acute ST-elevation myocardial infarction in comparison with single-photon emission tomography using Tc99m-Sestamibi.
201448 citationsauthor #8
Randomized comparison of biolimus-eluting stents with biodegradable polymer versus everolimus-eluting stents with permanent polymer coatings assessed by optical coherence tomography
201434 citationsauthor #11
Three‐Dimensional Echocardiographic Optimization Improves Outcome in Cardiac Resynchronization Therapy Compared to ECG Optimization: A Randomized Comparison
201414 citationsauthor #10
One-year outcomes with abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary interventions in patients with non-ST-segment elevation myocardial infarction: updated results from the ISAR-REACT 4 trial.
201320 citationsauthor #11
High frequency of CYP2C19*2 carriers in PCI-treated patients switched over from clopidogrel to prasugrel based on platelet function monitoring
20133 citationsauthor #6
Association of ST-elevation and non-ST-elevation presentation on ECG with transmurality and size of myocardial infarction as assessed by contrast-enhanced magnetic resonance imaging.
201332 citationsauthor #7
Early vascular healing with rapid breakdown biodegradable polymer sirolimus-eluting versus durable polymer everolimus-eluting stents assessed by optical coherence tomography.
201323 citationsauthor #12
Statin pretreatment and presentation patterns in patients with coronary artery disease.
201314 citationsauthor #6
The Upfront Risks of Vascular Access Complications
20130 citationsauthor #3
Comparative efficacy of 2 zotarolimus-eluting stent generations: resolute versus endeavor stents in patients with coronary artery disease.
201335 citationsauthor #7
Polymer-free sirolimus-eluting versus polymer-based paclitaxel-eluting stents: an individual patient data analysis of randomized trials.
20138 citationsauthor #8
The assessment of area at risk and myocardial salvage after coronary revascularization in acute myocardial infarction: comparison between CMR and SPECT.
201339 citationsauthor #7
Relation of fibrinogen level with cardiovascular events in patients with coronary artery disease.
201350 citationsauthor #8
Prognostic value of uric acid in patients with Type 2 diabetes mellitus and coronary artery disease.
201321 citationsauthor #9
Five‐year clinical outcomes of a polymer‐free sirolimus‐eluting stent versus a permanent polymer paclitaxel‐eluting stent: Final results of the intracoronary stenting and angiographic restenosis – test equivalence between two drug‐eluting stents (ISAR‐TEST) trial
201351 citationsauthor #4
Gender differences in contrast-enhanced magnetic resonance imaging after acute myocardial infarction
201310 citationsauthor #6
Second‐versus first‐generation “Limus”‐eluting stents in diabetic patients with coronary artery disease: A randomized comparison in setting of ISAR‐TEST‐4 trial
201319 citationsauthor #8
Antiplatelet efficacy of prasugrel in patients with high on-clopidogrel treatment platelet reactivity and a history of coronary stenting
201316 citationsauthor #6
Validity of cardiac implantable electronic devices in assessing daily physical activity.
201330 citationsauthor #6
Uric acid and prognosis in angiography‐proven coronary artery disease
201343 citationsauthor #9
Reproducibility of area at risk assessment in acute myocardial infarction by T1- and T2-mapping sequences in cardiac magnetic resonance imaging in comparison to Tc99m-Sestamibi SPECT
20136 citationsauthor #3
Two Rare Variants Explain Association with Acute Myocardial Infarction in an Extended Genomic Region Including the Apolipoprotein(A) Gene
201314 citationsauthor #6
Prehospital statin therapy and one-year mortality in patients with stable coronary artery disease undergoing percutaneous coronary intervention.
20133 citationsauthor #6
acute myocardial infarction Urokinase receptor surface expression regulates monocyte adhesion in
20130 citationsauthor #1
A prospective randomized trial comparing the recovery of platelet function after loading dose administration of prasugrel or clopidogrel
201314 citationsauthor #9
Everolimus-eluting versus sirolimus-eluting stents: an updated meta-analysis of randomized trials
201250 citationsauthor #9
A patient with angina at night: core curriculum chapters 3 (non-invasive imaging) and 9 (chronic ischaemic heart disease)
20120 citationsauthor #9
Gender differences in contrast-enhanced magnetic resonance imaging after acute myocardial infarction
20120 citationsauthor #3
Bivalirudin Versus Heparin Plus a Glycoprotein IIb/IIIa Inhibitor in Patients With Non–ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention After Clopidogrel Pretreatment: Pooled Analysis from the ACUITY and ISAR-REACT 4 Trials
201235 citationsauthor #8
Prognostic value of coronary computed tomography angiography during 5 years of follow-up in patients with suspected coronary artery disease.
2012188 citationsauthor #6
Association of coronary atherosclerotic burden with clinical presentation and prognosis in patients with stable and unstable coronary artery disease
201244 citationsauthor #8
ST-segment resolution after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.
201225 citationsauthor #5
Erratum to: Gender differences in contrast-enhanced magnetic resonance imaging after acute myocardial infarction
20122 citationsauthor #6
Erythropoietin-induced progenitor cell mobilisation in patients with acute ST-segment-elevation myocardial infarction and restenosis
201213 citationsauthor #12
Intra-aortic balloon counterpulsation in patients with acute myocardial infarction without cardiogenic shock. A meta-analysis of randomized trials.
201224 citationsauthor #6
Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials.
2012394 citationsauthor #8
Validation of the Bleeding Academic Research Consortium Definition of Bleeding in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
2012237 citationsauthor #11
Abstract 12407: Three Dimensional and Doppler Echocardiographic Parameters Predict Response to Cardiac Resynchronization Therapy
20120 citationsauthor #8
Acute Beneficial Hemodynamic Effects of a Novel 3D-Echocardiographic Optimization Protocol in Cardiac Resynchronization Therapy
201212 citationsauthor #9
Drug-eluting versus bare-metal stents in saphenous vein graft lesions – Author's reply
20120 citationsauthor #5
Association of uric acid with mortality in patients with stable coronary artery disease.
201263 citationsauthor #7
AS-095 Differential Vascular Healing Patterns with Rapid Absorption Biodegradable Polymer Sirolimus-Eluting Stents versus Durable Polymer Everolimus-Eluting Stents
20120 citationsauthor #7
Prognostic value of coronary computed tomographic angiography in patients with arterial hypertension
20125 citationsauthor #7
Comparison between magnetic resonance imaging and single-photon emission tomography for the assessment of myocardial salvage after coronary revascularization in acute myocardial infarction
20122 citationsauthor #5
Image quality and radiation exposure with prospectively ECG-triggered axial scanning for coronary CT angiography: the multicenter, multivendor, randomized PROTECTION-III study.
2012179 citationsauthor #15
Percutaneous Coronary Intervention in Acute ST Segment Elevation Myocardial Infarction
20120 citationsauthor #1
Cardiovascular risk assessment based on the quantification of coronary calcium in contrast-enhanced coronary computed tomography angiography.
201242 citationsauthor #6
Prognostic value of uric acid in patients with acute coronary syndromes.
201297 citationsauthor #8
Association of midregional proadrenomedullin with coronary artery stenoses, soft atherosclerotic plaques and coronary artery calcium
20123 citationsauthor #8
TCT-295 Neointimal growth patterns after between biodegradable polymer biolimus-eluting or permanent polymer everolimus-eluting stent implantation assessed with newly developed “spread-out neointimal topography”: Results from ISAR-TEST6 OCT trial
20120 citationsauthor #10
No Association of ABCB1 C3435T Genotype With Clopidogrel Response or Risk of Stent Thrombosis in Patients Undergoing Coronary Stenting
201245 citationsauthor #9
TCT-673 Drug-eluting stents versus bare metal stents for saphenous vein graft lesions: meta-analysis of randomized trials
20120 citationsauthor #10
Effect of Gallopamil on Myocardial Ischaemia During Percutaneous Transluminal Coronary Angioplasty
20124 citationsauthor #9
DIFFERENTIAL VASCULAR HEALING PATTERNS WITH RAPID ABSORPTION BIODEGRADABLE POLYMER SIROLIMUS-ELUTING STENTS VERSUS DURABLE POLYMER EVEROLIMUS-ELUTING STENTS
20120 citationsauthor #6
TCT-667 Restenosis after coronary stenting in 10,004 patients with follow-up angiography
20120 citationsauthor #8
SUPPLEMENTAL MATERIAL No Association of ABCB 1 C 3435 T Genotype with Clopidogrel Response or Risk of Stent Thrombosis in Patients Undergoing Coronary Stenting
20120 citationsauthor #9
IMPACT OF CALCIUM CHANNEL BLOCKERS ON THE PHARMACODYNAMIC EFFECT AND THE CLINICAL EFFICACY OF CLOPIDOGREL AFTER DRUG ELUTING STENTING
20110 citationsauthor #6
Sensitive troponin and N‐terminal probrain natriuretic peptide in stable angina
201113 citationsauthor #9
Interleukin 18 gene variation and risk of acute myocardial infarction.
201120 citationsauthor #4
Effects of G-CSF on systemic inflammation, coagulation and platelet activation in patients with acute myocardial infarction.
201118 citationsauthor #9
EXTENT OF ATHEROSCLEROSIS IRRESPECTIVE OF STENOSIS IS A BETTER OUTCOME PREDICTOR THAN NUMBER OF OBSTRUCTED VESSELS IN INVASIVE CORONARY ANGIOGRAPHY
20110 citationsauthor #4
feasibility and safety study: The ACTION trial Actinomycin-eluting stent for coronary revascularization: A randomized
20110 citationsauthor #13
Five‐year clinical outcomes of sirolimus‐eluting versus paclitaxel‐eluting stents in high‐risk patients
201121 citationsauthor #10
MRI of Coronary Wall Remodeling in a Swine Model of Coronary Injury Using an Elastin-Binding Contrast Agent
201178 citationsauthor #14
A meta-analysis of specifically designed randomized trials of sirolimus-eluting versus paclitaxel-eluting stents in diabetic patients with coronary artery disease.
201125 citationsauthor #12
Intervention-Based Strategy in Patients With Stable Coronary Artery Disease A Meta-Analysis of 17 Randomized Trials of a Percutaneous Coronary
201114 citationsauthor #2
Gadolinium-enhanced cardiovascular magnetic resonance for the detection and characterization of Loeffler endocarditis in patients with hypereosinophilic syndrome.
20114 citationsauthor #7
Impact of therapy with statins, beta-blockers and angiotensin-converting enzyme inhibitors on plasma myeloperoxidase in patients with coronary artery disease
201119 citationsauthor #3
Mutations in the mitochondrial thioredoxin reductase gene TXNRD2 cause dilated cardiomyopathy.
2011106 citationsauthor #18
Molecular imaging of vascular 18F-FDG uptake with PET/CT in patients early after an acute coronary syndrome
20110 citationsauthor #5
Variations of specific non-candidate genes and risk of myocardial infarction: a replication study.
201115 citationsauthor #3
PROGNOSTIC VALUE OF MICROVASCULAR OBSTRUCTION ASSESSED BY CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING IN COMPARISON TO TC99M-SESTAMIBI SPECT IN ACUTE MYOCARDIAL INFARCTION
20113 citationsauthor #5
Long-term outcome after sirolimus-eluting stents versus bare metal stents in patients with Diabetes mellitus: a patient-level meta-analysis of randomized trials
201138 citationsauthor #7
Prognostic value of sensitive troponin T in patients with stable and unstable angina and undetectable conventional troponin.
201155 citationsauthor #15
Polymer-free sirolimus- and probucol-eluting versus new generation zotarolimus-eluting stents in coronary artery disease: the Intracoronary Stenting and Angiographic Results: Test Efficacy of Sirolimus- and Probucol-Eluting versus Zotarolimus-eluting Stents (ISAR-TEST 5) trial.
2011140 citationsauthor #10
ACUTE HEMODYNAMIC OUTCOME AND CLINICAL IMPACT OF PERCUTANEOUS EDGE-TO-EDGE MITRAL VALVE REPAIR USING THE MITRACLIP SYSTEM IN A REAL WORLD SETTING
20110 citationsauthor #7
Population 64-Slice Computed Tomographic Angiography in an Unselected Patient Improved Noninvasive Assessment of Coronary Artery Bypass Grafts With
20116 citationsauthor #1
Modulated neurotransmission in rat, guinea pig, and human cardiac tissue Effect of myocardial ischemia on stimulation-evoked noradrenaline release.
20110 citationsauthor #6
Impact of smoking on antiplatelet effect of clopidogrel and prasugrel after loading dose and on maintenance therapy.
201162 citationsauthor #12
Statin effect on thrombin inhibitor effectiveness during percutaneous coronary intervention: a post-hoc analysis from the ISAR-REACT 3 trial
20116 citationsauthor #12
Extended evidence for association between the melanoma inhibitory activity 3 gene and myocardial infarction
20118 citationsauthor #5
Temporal changes of microvascular obstruction and infarct border zone after acute myocardial infarction assessed by contrast enhanced magnetic resonance imaging
20110 citationsauthor #4
Diagnostic value of standard and extended ECG leads for the detection of acute myocardial infarction as compared to contrast-enhanced magnetic resonance imaging.
20115 citationsauthor #6
The chromosome 9p21 region and myocardial infarction in a European population.
201126 citationsauthor #7
Erratum to: Long-term outcome after sirolimus-eluting stents versus bare metal stents in patients with Diabetes mellitus: a patient-level meta-analysis of randomized trials
20110 citationsauthor #7
Efficacy of reperfusion with primary percutaneous coronary intervention in patients with acute ST segment elevation myocardial infarction
20111 citationsauthor #2

TIMELINE

1972 12 citations

1974 28 citations

1975 9 citations

1976 4 citations

1977 2 citations

1978 12 citations

1979 17 citations

1980 71 citations

1981 69 citations

1982 157 citations

1983 39 citations

1984 52 citations

1985 57 citations

1986 36 citations

1987 50 citations

1988 68 citations

1989 111 citations

1990 181 citations

1991 76 citations

1992 35 citations

1993 144 citations

1994 495 citations

1995 194 citations

1996 164 citations

1997 793 citations

1998 205 citations

1999 1,185 citations

2000 826 citations

2001 1,688 citations

2002 1,600 citations

2003 2,357 citations

2004 3,310 citations

2005 4,630 citations

2006 5,248 citations

2007 5,321 citations

2008 4,883 citations

2009 5,047 citations

2010 4,748 citations

2011 1,844 citations

2012 1,464 citations

2013 451 citations

2014 117 citations

2015 434 citations

2016 0 citations

2017 0 citations

2020 0 citations

2021 6 citations

2023 9 citations

Unknown 0 citations

A. Schömig

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT